2 years ago
VSTM
AnalystsMara GoldsteinMara Goldstein's Stock Forecasts
AnalystsMara Goldstein
Sectors:
Analyst Ranking
Bottom 9%
#4493 out of 4922 analysts
Average Return
-6.37%
Win Rate
30%14 out of 47
Risk vs Reward
Poor
Good
Mara Goldstein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Fate Therapeutics IncFATE | +383.57% | $19.36 | $93.62 | 2019-12-29 - 2020-12-30 | Strong Buy |
Forty Seven IncFTSV | +172.63% | $34.66 | $94.48 | 2019-12-09 - 2020-03-04 | Strong Buy |
Autolus Therapeutics PLCAUTL | +164.22% | $2.04 | $5.39 | 2023-03-07 - 2024-03-07 | Strong Buy |
Iovance Biotherapeutics IncIOVA | +96.20% | $5.27 | $10.34 | 2023-09-14 - 2024-09-13 | Strong Buy |
Verastem IncVSTM | +78.66% | $59.04 | $105.48 | 2017-09-05 - 2018-09-06 | Strong Buy |
Mara Goldstein Analyst Color
Get additional color on Mara Goldstein's coverage of popular stocks
Mara Goldstein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kura Oncology IncKURA | 3 | Buy | $30.00 | +429.10% | Maintains | a month ago |
Iovance Biotherapeutics IncIOVA | 5 | Buy | $10.00 | +491.72% | Maintains | 2 months ago |
Verastem IncVSTM | 7 | Buy | $8.00 | +92.77% | Maintains | 3 months ago |
Arcus Biosciences IncRCUS | 4 | Strong Buy | $42.00 | N/A | Maintains | a year ago |
Xencor IncXNCR | 2 | Strong Buy | $50.00 | N/A | Maintains | a year ago |
Syndax Pharmaceuticals IncSNDX | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Incyte CorpINCY | 4 | Hold | $77.00 | N/A | Maintains | 2 years ago |
Erasca IncERAS | 3 | Strong Buy | $7.00 | N/A | Maintains | 2 years ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Leap Therapeutics IncLPTX | 5 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Nektar TherapeuticsNKTR | 3 | Hold | $90.00 | N/A | Reiterates | 2 years ago |
Corvus Pharmaceuticals IncCRVS | 4 | Hold | $3.50 | N/A | Reiterates | 2 years ago |
Neurogene IncNGNE | 3 | Hold | $7.50 | N/A | Maintains | 2 years ago |
In8bio IncINAB | 2 | Strong Buy | $360.00 | N/A | Reiterates | 2 years ago |
Immuneering CorpIMRX | 2 | Strong Buy | $20.00 | N/A | Upgrades | 2 years ago |
Merck & Co IncMRK | 2 | Strong Buy | $130.00 | N/A | Reiterates | 2 years ago |
Cytomx Therapeutics IncCTMX | 3 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Hold | $1.72 | N/A | Downgrades | 2 years ago |
Autolus Therapeutics PLCAUTL | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Adaptimmune Therapeutics PLCADAP | 2 | Strong Buy | $9.00 | N/A | Upgrades | 3 years ago |
Effector Therapeutics IncEFTR | 1 | Strong Buy | $500.00 | N/A | Initiates Coverage On | 4 years ago |
Kadmon Holdings IncKDMN | 1 | Hold | $9.50 | N/A | Downgrades | 4 years ago |
Forty Seven IncFTSV | 2 | Hold | $95.50 | N/A | Downgrades | 5 years ago |
Array Technologies IncARRY | 3 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 7 years ago |
Celldex Therapeutics IncCLDX | 1 | Hold | $45.00 | N/A | Maintains | 7 years ago |
Ayala Pharmaceuticals IncADXS | 1 | Strong Buy | $6,000.00 | N/A | Maintains | 7 years ago |
Ardelyx IncARDX | 1 | Strong Buy | $14.00 | N/A | Maintains | 8 years ago |
Applied Genetic Technologies CorpAGTC | 1 | Hold | $9.00 | N/A | Maintains | 8 years ago |
Progenics Pharmaceuticals IncPGNX | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 8 years ago |
Oncomed Pharmaceuticals IncOMED | 1 | Hold | $6.00 | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.